Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection

Infection and Immunity

Volumn 75, Issue 6, 2007, Pages 3055-3061

  Rudner, Xiaowen L ^a   Happel, Kyle I ^a   Young, Erana A ^a   Shellito, Judd E ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 23; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; NEUTRALIZING ANTIBODY; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; EFFECTOR CELL; HOST RESISTANCE; LUNG ALVEOLUS MACROPHAGE; LUNG MYCOSIS; MOUSE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CYTOKINES; HOST-PARASITE RELATIONS; INTERLEUKIN-17; INTERLEUKIN-23; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS;

EID: 34249869268     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01329-06     Document Type: Article

References (44)

1. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, and A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910-1914.
2. Bang, D., J. Emborg, J. Elkjaer, J. D. Lundgren, and T. L. Benfield. 2001. Independent risk of mechanical ventilation for AIDS-related Pneumocystis carinii pneumonia associated with bronchoalveolar lavage neutrophilia. Respir. Med. 95:661-665.
3. Beck, J., M. Warnock, J. Curtis, M. Sniezek. S. Arrag-Peffer, H. Kaltreider, and J. Snellito. 1991. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am. J. Respir. Cell Mol. Biol. 5:186-197.
4. Carr, J. A., J. A. Rogerson, M. J. Mulqueen, N. A. Roberts, and A. A. Nash. 1999. The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40. J. Interferon Cytokine Res. 19:1145-1152.
5. Decken, K., G. Kohler, K. Palmer-Lehmann, A. Wunderlin, F. Mattner, J. Magram, M. K. Gately, and G. Alber. 1998. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66:4994-5000.
6. Elkins, K. L., A. M. Cooper, S. M. Colombini, S. C. Cowley, and T. L. Kieffer. 2002. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12p70. Infect. Immun. 70:1936-1948.
7. Garvy, B., A. Ezekowitz, and A. Harmsen. 1997. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect. Immun. 65:373-379.
8. Ghilardi, N., N. Kljavin, Q. Chen, S. Lucas, A. L. Gurney, and F. J. De Sauvage. 2004. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J. Immunol. 172:2827-2833.
9. Hanano, R., K. Reifenberg, and S. Kaufmann. 1998. Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii. Infect. Immun. 66:305-314.
10. Happel, K. L., P. J. Dubin, M. Zheng, N. Ghilardi, C. Lockhart, L. J. Quinten, A. R. Odden, J. E. Snellito, G. J. Bagby, S. Nelson, and J. K. Kolls. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202:761-769.
11. Happel, K. L., M. Zheng, E. Young, L. J. Quinten, E. Lockhart, A. J. Ramsay, J. E. Snellito, J. R. Schurr, G. J. Bagby, S. Nelson, and J. K. Kolls. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170:4432-4436.
12. Harmsen, A., and M. Stankiewicz. 1990. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172:937-945.
13. Holscher, C., R. A. Atkinson, B. Arendse, N. Brown, E. Myburgh, G. Alber, and F. Brombacher. 2001. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167:6957-6966.
14. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5:521-531.
15. Ieki, R., T. Furata, S. Asano, S. Mori, S. Kudoh, H. Kimura, and F. Takaku. 1989. Effect of recombinant human granulocyte colony-stimulating factor on Pneumocystis carinii infection in nude mice. Jpn. J. Exp. Med. 59:51-58.
16. Khader, S. A., J. E. Pearl, K. Sakamoto, L. Gilmartin, G. K. Bell, D. M. Jelley-Gibbs, N. Ghilardi, F. Desauvage, and A. M. Cooper. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J. Immunol. 175:788-795.
17. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240.
18. Langrish, C. L., B. S. McKenzie, N. J. Wilson, R. de Waal Malefyt, R. A. Kastelein, and D. J. Cua. 2004. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202:96-105.
19. Lehmann, J., S. Bellmann, C. Werner, R. Schroder, N. Schutze, and G. Alber. 2001. IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis. J. Immunol. 167:5304-5315.
20. Lieberman, L. A., F. Cardillo, A. M. Owyang, D. M. Rennick, D. J. Cua, R. A. Kastelein, and C. A. Hunter. 2004. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J. Immunol. 173:1887-1893.
21. Limper, A. H., K. P. Offord, T. F. Smith, and W. J. Martin II. 1989. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204-1209.
22. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatten, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231-234.
23. Mason, G. R., C. H. Hashimoto, P. S. Dickman, L. F. Foutty, and C. J. Cobb. 1989. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am. Rev. Respir. Dis. 139:1336-1342.
24. McKenzie, B. S., R. A. Kastelein, and D. J. Cua. 2006. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27:17-23.
25. Murphy, C. A., C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951-1957.
26. Murray, J., C. Felton, and S. Garay. 1984. Pulmonary complications of the acquired immunodeficiency syndrome: report of a National Heart, Lung and Blood Institute workshop. N. Engl. J. Med. 310:1682-1688.
27. Murray, J., S. Garay, P. Hopewell, J. Mills, G. Snider, and D. Stover. 1987. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Am. Rev. Respir. Dis. 135:504-509.
28. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, F. Zonin, E. Vaisberg, T. Churakova, M. Liu, D. Gorman, J. Wagner, S. Zurawski, Y. Liu, J. S. Abrams, K. W. Moore, D. Rennick, R. de Waal-Malefyt, C. Hannum, J. F. Bazan, and R. A. Kastelein. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-725.
29. Parham, C., M. Chirica, J. Timans, E. Vaisberg, M. Travis, J. Cheung, S. Pflanz, R. Zhang, K. P. Singh, F. Vega, W. To, J. Wagner, A. M. O'Farrell, T. McClanahan, S. Zurawski, C. Hannum, D. Gorman, D. M. Rennick, R. A. Kastelein, R. de Waal Malefyt, and K. W. Moore. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168:5699-5708.
30. Phair, J., A. Munoz, R. Detels, R. Kaslow, C. Rinaldo, and A. Saah. 1990. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeixiency virus type 1. N. Engl. J. Med. 322:161-165.
31. Pirhonen, J., S. Matikainen, and I. Julkunen. 2002. Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J. Immunol. 169:5673-5678.
32. Quinten, L. J., S. Nelson, D. M. Boe, P. Zhang, Q. Zhong, J. K. Kolls, and G. J. Bagby. 2002. The granulocyte colony-stimulating factor response after intrapulmonary and systemic bacterial challenges. J. Infect. Dis. 185:1476-1482.
33. Re, F., and J. L. Strominger. 2001. Toll-like receptor 2 (TLR2) and TRL4 differentially activate human dendritic cells. J. Biol. Chem. 276:37692.
34. Roths, J., and C. Sidman. 1992. Both immunity and hyperrcsponsivencss to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. J. Clin. Investig. 90:673-678.
35. Shellito, J., V. V. Suzara, W. Blumenfeld, J. M. Beck, H. J. Steger, and T. H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Investig. 85:1686-1693.
36. Stansell, J. D., D. H. Osmond, E. Charlebois, L. LaVange, J. M. Wallace, B. V. Alexander, J. Glassroth, P. A. Kvale, M. J. Rosen, L. B. Reichman, J. R. Turner, P. C. Hopewell, et al. 1997. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Am. J. Respir. Crit. Care Med. 155:60-66.
37. Steele, C., J. E. Shellito, and J. K. Kolls. 2005. Immunity against the opportunistic fungal pathogen Pneumocystis. Med. Mycol. 43:1-19.
38. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of lL-17-producing T cells. Immunity 24:179-189.
39. Veldhoen, M., and B. Stockinger. 2006. TGFbeta1, a 'Jack of all trades': the link with pro-inflammatory IL-17-producing T cells. Trends Immunol. 27:358-361.
40. Walzer, P., C. Kim, M. Linke, C. Pogue, M. Huerkamp, C. Chrisp, A. Lerro, S. Wixson, E. Hall, and L. Shultz. 1989. Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodcficient mice. Infect. Immun. 57:62-70.
41. Ward, S. G., and J. Westwick. 1998. Chemokines: understanding their role in T-lymphocytc biology. Biochem. J. 333:457-470.
42. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677-688.
43. Wynn, T. A. 2005. T(H)-17: a giant step from T(H)1 and T(H)2. Nat. Immunol. 6:1069-1070.
44. Zheng, M., J. Shellito, L. Marrero, Q. Zhong, J. Stewart, P. Ye, V. Wallace, P. Schwarzenberger, and J. Kolls. 2001. CD4+ T cell independent vaccination against Pneumocystis carinii in mice. J. Clin. Investig. 108:1469-1474.